1. Signaling Pathways
  2. Autophagy
  3. LRRK2

LRRK2

Leucine-rich repeat kinase 2 (LRRK2) is an enzyme that in humans is encoded by the PARK8 gene. LRRK2 is a member of the leucine-rich repeat kinase family. Variants of this gene are associated with an increased risk of Parkinson's disease (PD)and also Crohn's disease (CD).

Leucine-rich repeat kinase 2 (LRRK2) is the gene responsible for autosomal-dominant PD, PARK8, which is originally defined by linkage analysis of a Japanese family. LRRK2 is a complex kinase consisting of LRR, ROC, COR, kinase, and WD40 domains. LRRK2 plays a key role in axonal extension, autophagy, proliferation, and survival of neurons. In addition to neurons, LRRK2 is highly expressed in immune cells such as B cells, macrophages, and microglia. Several studies have demonstrated that LRRK2 is related to inflammatory responses of microglia that could be involved in the development and progression of neurodegeneration.

LRRK2 is a large, multidomain protein containing two catalytic domains: a Ras of complex proteins (Roc) G-domain and a kinase domain. Leucine-rich repeat kinase 2 (LRRK2) represents a promising drug target for treatment and prevention of Parkinson’s disease (PD), because mutations in LRRK2 are the most common cause of Mendelian forms of the disease. PD-associated LRRK2 variants show decreased GTPase and increased kinase activity.

LRRK2 相关产品 (16):

Cat. No. Product Name Effect Purity
  • HY-100411
    MLi-2 Inhibitor 99.66%
    MLi-2是高效选择的,具有口服活性,可渗透大脑的LRRK2抑制剂。IC50值为0.76 nM。
  • HY-10875
    LRRK2-IN-1 Inhibitor 99.38%
    LRRK2-IN-1 是一种有效的,选择性的 LRRK2 抑制剂,作用于 LRRK2 (G2019S) 和 LRRK2 (WT),IC50 值分别为 6 nM 和 13 nM。
  • HY-13687
    IKK 16 Inhibitor 99.78%
    IKK 16 是一种选择性的 IκB 激酶 (IKK) 抑制剂,作用于 IKK2IKK complexIKK1IC50 分别为 40 nM,70 nM 和 200 nM。IKK 16 还抑制富亮氨酸重复激酶 2 (LRRK 2),IC50 为 50 nM。
  • HY-12477
    PF-06447475 Inhibitor 99.88%
    PF-06447475是高效,选择性,能透过血脑屏障的 LRRK2 抑制剂,IC50值为3 nM。
  • HY-13237
    GSK2578215A Inhibitor 99.86%
    GSK2578215A 是 一种有效的选择性 LRRK2 抑制剂,作用于野生型 LRRK2 和 G2019S 突变型,IC50 值都约为 10 nM。
  • HY-13687A
    IKK 16 hydrochloride Inhibitor
    IKK 16 hydrochloride 是一种选择性的 IκB 激酶 (IKK) 抑制剂,作用于 IKK2IKK complexIKK1IC50 分别为 40 nM,70 nM 和 200 nM。IKK 16 还抑制富亮氨酸重复激酶 2 (LRRK 2),IC50 为 50 nM。
  • HY-111493
    LRRK2 inhibitor 1 Inhibitor 99.72%
    LRRK2 inhibitor 1是有效,选择性的 LRRK2 抑制剂,IC50为6.8 nM。
  • HY-18163
    GNE-7915 Inhibitor 99.48%
    GNE-7915是高效选择性,可渗透大脑的LRRK2抑制剂,IC50值为9 nM。
  • HY-12282
    GNE-9605 Inhibitor 99.26%
    GNE 9605是一个高效,选择性和能脑渗透的LRRK2抑制剂,IC50为19 nM。
  • HY-15796
    GNE0877 Inhibitor 98.64%
    GNE0877是高活性、选择性、可通透脑屏障的LRRK2抑制剂,IC50为3 nM。
  • HY-16936
    JH-II-127 Inhibitor 98.66%
    JH-II-127是一种高效的选择性, 脑渗透性LRRK2 抑制剂, 抑制LRRK2野生型, LRRK2-G2019S,和 LRRK2-A2016T, IC50 值分别为6.6 nM, 2.2 nM ,47.7 nM。
  • HY-B0792
    CZC-54252 Inhibitor 99.26%
    CZC-54252是LRRK2高效抑制剂,对野生型LRRK2和突变型G2019S LRRK2的IC50值分别为1.28和1.85nM。
  • HY-18163A
    GNE-7915 tosylate Inhibitor 98.94%
    GNE-7915 tosylate是高效选择性,可渗透大脑的LRRK2抑制剂,IC50值为9 nM。
  • HY-13488
    HG-10-102-01 Inhibitor 99.54%
    HG-10-102-01是野生型LRRK2和突变型G2019S抑制剂,IC50分别为23.3 nM和3.2 nM。
  • HY-15800A
    CZC-25146 Inhibitor 98.24%
    CZC-25146是代谢稳定性的LRRK2抑制剂,对野生型LRRK2和G2019S LRRK2的IC50分别为4.76 nM和6.87 nM。
  • HY-15800
    CZC-25146 hydrochloride Inhibitor
    CZC-25146盐酸盐是代谢稳定的LRRK2选择性抑制剂,对野生型LRRK2和G2019S LRRK2的IC50分别为4.76 nM和6.87 nM。
Isoform Specific Products

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

江苏快三 江苏快3 江苏快三 江苏快3 江苏快三 江苏快3 江苏快3 江苏快3 江苏快三 江苏快3